Gerstein Fisher’s iRadimed IRMD Stock Holding History

Gerstein Fisher’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-40,459	Closed	-$775K	–	425
2016 Q1	$775K	Hold	40,459	–	–	0.11%	168
2015 Q4	$1.13M	Buy	+40,459	New	+$1.14M	0.16%	132

Other funds holding IRMD

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerstein Fisher's IRMD Position: Q2 2016 in Review

Gerstein Fisher sold out of iRadimed (IRMD) in Q2 2016, closing a stake of 40,459 shares — an estimated $775K sold.

Gerstein Fisher first reported a position in IRMD in Q4 2015 and held it in 2 quarters. The position peaked at $1.13M in Q4 2015. 60 funds tracked by Wall St. Rank hold IRMD as of Q2 2016.

Gerstein Fisher reported no remaining iRadimed position as of Q2 2016 after selling out during the quarter.
Gerstein Fisher sold 40,459 iRadimed shares in Q2 2016, an estimated $775K.
Gerstein Fisher first reported a position in iRadimed in Q4 2015 and held it in 2 quarters.
Gerstein Fisher's iRadimed position peaked at $1.13M in Q4 2015.
60 funds tracked by Wall St. Rank held iRadimed as of Q2 2016.

Based on Gerstein Fisher's 13F filing for Q2 2016, filed 8 Aug 2016.